BCWM
GSK icon

Bartlett & Co Wealth Management’s GSK GSK Stock Holding History

Bartlett & Co Wealth Management’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$67.8K Hold
1,332
– – ﹤0.01% 626
2025
Q4 		$65.9K Sell
1,332
-364
-21% -$17K ﹤0.01% 616
2025
Q3 		$74K Buy
1,696
+84
+5% +$3.28K ﹤0.01% 604
2025
Q2 		$62.5K Buy
1,612
+256
+19% +$9.78K ﹤0.01% 620
2025
Q1 		$53.1K Hold
1,356
– – ﹤0.01% 639
2024
Q4 		$46.4K Buy
1,356
+37
+3% +$1.33K ﹤0.01% 665
2024
Q3 		$54.4K Hold
1,319
– – ﹤0.01% 640
2024
Q2 		$51.8K Hold
1,319
– – ﹤0.01% 650
2024
Q1 		$57.4K Hold
1,319
– – ﹤0.01% 642
2023
Q4 		$49.4K Sell
1,319
-240
-15% -$8.62K ﹤0.01% 708
2023
Q3 		$57K Hold
1,559
– – ﹤0.01% 640
2023
Q2 		$56K Hold
1,559
– – ﹤0.01% 649
2023
Q1 		$55.9K Hold
1,559
– – ﹤0.01% 554
2022
Q4 		$55.2K Hold
1,559
– – ﹤0.01% 563
2022
Q3 		$46.4K Sell
1,559
-159
-9% -$6.03K ﹤0.01% 575
2022
Q2 		$94.1K Buy
1,718
+159
+10% +$8.78K ﹤0.01% 468
2022
Q1 		$86.1K Buy
+1,559
New +$84.7K ﹤0.01% 505
2021
Q4 		– Sell
-1,559
Closed -$75.7K – 587
2021
Q3 		$75.7K Sell
1,559
-775
-33% -$38.9K ﹤0.01% 453
2021
Q2 		$118K Hold
2,334
– – ﹤0.01% 390
2021
Q1 		$106K Sell
2,334
-796
-25% -$36.1K ﹤0.01% 403
2020
Q4 		$146K Sell
3,130
-896
-22% -$41.2K ﹤0.01% 356
2020
Q3 		$192K Hold
4,026
– – ﹤0.01% 314
2020
Q2 		$208K Hold
4,026
– – 0.01% 305
2020
Q1 		$192K Buy
4,026
+896
+29% +$47.8K 0.01% 296
2019
Q4 		$185K Sell
3,130
-160
-5% -$8.9K ﹤0.01% 343
2019
Q3 		$177K Buy
3,290
+980
+42% +$50.4K ﹤0.01% 341
2019
Q2 		$117K Hold
2,310
– – ﹤0.01% 310
2019
Q1 		$123K Sell
2,310
-1,696
-42% -$84.7K ﹤0.01% 291
2018
Q4 		$194K Hold
4,006
– – 0.01% 252
2018
Q3 		$204K Hold
4,006
– – 0.01% 258
2018
Q2 		$204K Sell
4,006
-442
-10% -$22.3K 0.01% 251
2018
Q1 		$221K Buy
+4,448
New +$207K 0.01% 243

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Bartlett & Co Wealth Management's GSK Position: Q1 2026 in Review

Bartlett & Co Wealth Management held its GSK (GSK) position steady in Q1 2026 at 1,332 shares worth $67.8K. The position accounts for ﹤0.01% of the portfolio, ranked #626.

Bartlett & Co Wealth Management first reported a position in GSK in Q1 2018 and has held it in 32 quarters since. The position peaked at $221K in Q1 2018. 1,031 funds tracked by Wall St. Rank hold GSK as of Q1 2026.

  • Bartlett & Co Wealth Management held 1,332 shares of GSK worth $67.8K as of Q1 2026.
  • Bartlett & Co Wealth Management left its GSK share count unchanged in Q1 2026.
  • GSK made up ﹤0.01% of Bartlett & Co Wealth Management's portfolio in Q1 2026, its #626 holding.
  • Bartlett & Co Wealth Management first reported a position in GSK in Q1 2018 and has held it in 32 quarters since.
  • Bartlett & Co Wealth Management's GSK position peaked at $221K in Q1 2018.
  • 1,031 funds tracked by Wall St. Rank held GSK as of Q1 2026.

Based on Bartlett & Co Wealth Management's 13F filing for Q1 2026, filed 6 May 2026.